IGM Biosciences (IGMS) News Today $13.89 +0.30 (+2.21%) (As of 10/10/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period IGM Biosciences (NASDAQ:IGMS) Shares Down 3.7% - Time to Sell?IGM Biosciences (NASDAQ:IGMS) Stock Price Down 3.7% - Time to Sell?October 9 at 5:22 PM | marketbeat.comMarshall Wace LLP Has $737,000 Position in IGM Biosciences, Inc. (NASDAQ:IGMS)Marshall Wace LLP lifted its position in shares of IGM Biosciences, Inc. (NASDAQ:IGMS - Free Report) by 51.6% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 107,267 shares of the company's stock after buying an additional 36,491 sharesOctober 9 at 3:32 AM | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Trading 10.1% Higher - Time to Buy?October 6, 2024 | americanbankingnews.comIGM Biosciences (NASDAQ:IGMS) Trading 10.1% Higher - Here's What HappenedIGM Biosciences (NASDAQ:IGMS) Trading Up 10.1% - Time to Buy?October 4, 2024 | marketbeat.comAnalysts Set IGM Biosciences, Inc. (NASDAQ:IGMS) Price Target at $16.63October 4, 2024 | americanbankingnews.comQ3 2024 EPS Estimates for IGM Biosciences, Inc. (NASDAQ:IGMS) Increased by AnalystOctober 4, 2024 | americanbankingnews.comIGM Biosciences, Inc.: IGM Biosciences Announces Strategic Pivot to Focus Exclusively on AutoimmunityOctober 3, 2024 | finanznachrichten.deWedbush Comments on IGM Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:IGMS)IGM Biosciences, Inc. (NASDAQ:IGMS - Free Report) - Equities research analysts at Wedbush raised their Q3 2024 earnings per share estimates for IGM Biosciences in a report released on Tuesday, October 1st. Wedbush analyst R. Driscoll now anticipates that the company will earn ($0.83) per share foOctober 3, 2024 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Trading Down 7.4% on Analyst DowngradeOctober 3, 2024 | americanbankingnews.comIGM Biosciences (NASDAQ:IGMS) Shares Down 7.4% After Analyst DowngradeIGM Biosciences (NASDAQ:IGMS) Trading Down 7.4% After Analyst DowngradeOctober 2, 2024 | marketbeat.comJP Morgan Downgrades IGM Biosciences (IGMS)October 2, 2024 | msn.comTruist Securities Downgrades IGM Biosciences (IGMS)October 2, 2024 | msn.comIGM Biosciences, Inc. (NASDAQ:IGMS) Expected to Earn Q2 2025 Earnings of ($0.38) Per ShareOctober 2, 2024 | americanbankingnews.comIGM Biosciences (NASDAQ:IGMS) Stock Rating Lowered by JPMorgan Chase & Co.October 2, 2024 | americanbankingnews.comIGM Biosciences (NASDAQ:IGMS) Price Target Cut to $22.00 by Analysts at WedbushOctober 2, 2024 | americanbankingnews.comIGM Biosciences (NASDAQ:IGMS) Downgraded to "Hold" at Truist FinancialOctober 2, 2024 | americanbankingnews.comIGM Biosciences (NASDAQ:IGMS) Given New $20.00 Price Target at GuggenheimOctober 2, 2024 | americanbankingnews.comIGM Biosciences (NASDAQ:IGMS) Shares Gap Down Following Analyst DowngradeOctober 2, 2024 | americanbankingnews.comIGM Biosciences downgraded to Hold, stock fallsOctober 1, 2024 | seekingalpha.comIGM Biosciences: Hold Rating Amidst Strategic Shift and Leadership ChangesOctober 1, 2024 | markets.businessinsider.comIGM Biosciences’ stock tumbles as analysts weigh in on pivot plan with dismayOctober 1, 2024 | marketwatch.comIGM Biosciences (IGMS) Receives a Buy from WedbushOctober 1, 2024 | markets.businessinsider.comIGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEOOctober 1, 2024 | finance.yahoo.comGuggenheim Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $20.00Guggenheim reduced their price target on IGM Biosciences from $25.00 to $20.00 and set a "buy" rating on the stock in a research report on Tuesday.October 1, 2024 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Shares Gap Down on Analyst DowngradeIGM Biosciences (NASDAQ:IGMS) Shares Gap Down Following Analyst DowngradeOctober 1, 2024 | marketbeat.comRoyal Bank of Canada Lowers IGM Biosciences (NASDAQ:IGMS) Price Target to $17.00October 1, 2024 | americanbankingnews.comIGM Biosciences Shares Fall on Strategic Pivot to Autoimmunity, New CEOOctober 1, 2024 | marketwatch.comIGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionOctober 1, 2024 | msn.comIGM Biosciences (NASDAQ:IGMS) Downgraded to "Underweight" at JPMorgan Chase & Co.JPMorgan Chase & Co. cut shares of IGM Biosciences from a "neutral" rating to an "underweight" rating and decreased their price objective for the stock from $12.00 to $9.00 in a research report on Tuesday.October 1, 2024 | marketbeat.comIGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune DiseasesOctober 1, 2024 | barrons.comIGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Rating of "Moderate Buy" by BrokeragesIGM Biosciences, Inc. (NASDAQ:IGMS - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight brokerages that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to theOctober 1, 2024 | marketbeat.comUS says 40 foreign operators may be using Boeing 737s with suspect rudder control partsSeptember 30, 2024 | ca.finance.yahoo.comIGM Biosciences Announces Strategic Pivot to Focus Exclusively on AutoimmunitySeptember 30, 2024 | globenewswire.comWhile shareholders of IGM Biosciences (NASDAQ:IGMS) are in the black over 1 year, those who bought a week ago aren't so fortunateSeptember 27, 2024 | finance.yahoo.comAnalysts Are Bullish on These Healthcare Stocks: IGM Biosciences (IGMS), 4D Molecular Therapeutics (FDMT)September 19, 2024 | markets.businessinsider.comIGM Biosciences (NASDAQ:IGMS) Stock Price Down 4.1% on Insider SellingIGM Biosciences (NASDAQ:IGMS) Stock Price Down 4.1% on Insider SellingSeptember 18, 2024 | marketbeat.comIGM Biosciences, Inc. (NASDAQ:IGMS) CFO Misbah Tahir Sells 1,487 SharesSeptember 18, 2024 | insidertrades.comIGM Biosciences (NASDAQ:IGMS) Sets New 12-Month High at $18.34IGM Biosciences (NASDAQ:IGMS) Reaches New 12-Month High at $18.34September 17, 2024 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Stock Price Up 5.1%IGM Biosciences (NASDAQ:IGMS) Trading 5.1% HigherSeptember 16, 2024 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Stock Price Down 3.4%IGM Biosciences (NASDAQ:IGMS) Trading Down 3.4%September 12, 2024 | marketbeat.comIGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation SummitSeptember 10, 2024 | globenewswire.comIGM Biosciences (NASDAQ:IGMS) Trading Up 4.6%IGM Biosciences (NASDAQ:IGMS) Stock Price Up 4.6%September 10, 2024 | marketbeat.comQ3 2024 Earnings Forecast for IGM Biosciences, Inc. Issued By HC Wainwright (NASDAQ:IGMS)IGM Biosciences, Inc. (NASDAQ:IGMS - Free Report) - Analysts at HC Wainwright lifted their Q3 2024 earnings per share (EPS) estimates for IGM Biosciences in a research report issued on Thursday, September 5th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings of (September 9, 2024 | marketbeat.comIGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Rating of "Moderate Buy" by AnalystsShares of IGM Biosciences, Inc. (NASDAQ:IGMS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight research firms that are presently covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and four have given a buy rSeptember 6, 2024 | marketbeat.comIGM Biosciences: Hold Rating Affirmed Amid Financial Challenges and Clinical CatalystsSeptember 5, 2024 | markets.businessinsider.comThe Analyst Verdict: IGM Biosciences In The Eyes Of 5 ExpertsSeptember 5, 2024 | benzinga.comIGM Biosciences (NASDAQ:IGMS) Shares Down 4.4% After Analyst DowngradeIGM Biosciences (NASDAQ:IGMS) Shares Down 4.4% on Analyst DowngradeSeptember 5, 2024 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) PT Lowered to $11.00HC Wainwright lowered their target price on shares of IGM Biosciences from $12.00 to $11.00 and set a "neutral" rating for the company in a report on Thursday.September 5, 2024 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Trading 8.5% Higher IGM Biosciences (NASDAQ:IGMS) Trading 8.5% HigherSeptember 4, 2024 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Trading 9.8% Higher IGM Biosciences (NASDAQ:IGMS) Shares Up 9.8%August 29, 2024 | marketbeat.com Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address 24/7 Automated Profits in Crypto (Ad)What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life. >> Secure Your Spot On The Groundbreaking Workshop Here IGMS Media Mentions By Week IGMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGMS News Sentiment▼0.880.72▲Average Medical News Sentiment IGMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGMS Articles This Week▼93▲IGMS Articles Average Week Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AUPH News XNCR News CYRX News ZNTL News MLTX News RYTM News XENE News DYN News BHC News MRUS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IGMS) was last updated on 10/11/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
